Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

To improve quality of life for participants with advanced cancer, support their families, and lower overall cost of care.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participant is at least 18 years old presenting to the triage area of the MDACC ACCC for treatment

Participant has advanced lung or GI cancer. Advanced cancer patient defined as: locally recurrent or metastatic for which there is no curative treatment available.

Participant screens positive for at least 2 of 3 triple threat conditions (dyspnea, altered mental status, or poor performance status)

Participant has the ability to speak and write in English

Disqualifiers

Participant is already enrolled in hospice

Participant is comatose

Participant has severe intellectual disability

Participant has a history of dementia documented in the medical records

Trial design

Design model

Single group

Treatments tested in this trial

  • Standard of Care (Acute Cancer Care Center)

    Other intervention

    In Group 1, participants will receive the usual standard of care by an emergency care physician not trained in palliative care.

  • Standard of Care (Goals of Care)

    Other intervention

    In Group 2, participants will receive standard of care plus palliative care intervention by an emergency care physician trained in palliative care.

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: Acute Cancer Care CenterOther 1 intervention
Group B: Goals of CareOther 1 intervention

Trial outcomes

Primary outcomes

1

Quality Of Life Questionnaire

Time frame
through study completion; an average of 1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.